Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Evaluation of Sildenafil in PAH
NCT00483626Phase 4Unknown
- Sponsor
- Universidad de Chile
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ASP-001 in pulmonary arterial hypertension (PAH), sponsored by Universidad de Chile. Primary endpoint: Arterial pulmonary resistance index at 6 months. Status: unknown.
02
Drugs
ASP-001
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00483626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483626.